15 results on '"Andreasen, Lars Vibe"'
Search Results
2. First in man study:Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
3. First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
4. Aluminium hydroxide potentiates a protective Th1 biased immune response against polio virus that allows for dose sparing in mice and rats
5. Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma
6. Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma
7. Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
8. Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infection
9. Therapeutic Vaccination Using Cationic Liposome-Adjuvanted HIV Type 1 Peptides Representing HLA-Supertype-Restricted Subdominant T Cell Epitopes: Safety, Immunogenicity, and Feasibility in Guinea-Bissau
10. Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infection
11. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01
12. Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
13. The MediChew®technology platform
14. The MediChew® technology platform
15. First in man study: Bcl-Xl_42-CAF ® 09b vaccines in patients with locally advanced prostate cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.